- Report
- August 2022
- 118 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- October 2023
- 113 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- August 2022
- 116 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- October 2021
- 100 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- April 2024
- 134 Pages
Global
From €3651EUR$3,950USD£3,077GBP
- Report
- January 2024
- 140 Pages
Global
From €3928EUR$4,250USD£3,311GBP
- Report
- September 2023
- 143 Pages
Global
From €4113EUR$4,450USD£3,467GBP
- Report
- April 2025
- 70 Pages
Saudi Arabia
From €3235EUR$3,500USD£2,727GBP
- Report
- December 2024
- 85 Pages
India
From €3235EUR$3,500USD£2,727GBP
- Report
- October 2023
- 178 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- May 2023
- 140 Pages
Global
From €4574EUR$4,949USD£3,856GBP
- Report
- May 2023
- 147 Pages
Global
From €4574EUR$4,949USD£3,856GBP
- Report
- January 2024
- 200 Pages
Global
From €3835EUR$4,150USD£3,233GBP
- Report
- January 2024
- 200 Pages
Global
From €3835EUR$4,150USD£3,233GBP
- Report
- November 2023
- 170 Pages
Global
From €4113EUR$4,450USD£3,467GBP
- Report
- January 2023
- 170 Pages
Global
From €4113EUR$4,450USD£3,467GBP
- Report
- December 2022
- 206 Pages
Africa, Middle East, Turkey Africa, Middle East, Turkey
From €3189EUR$3,450USD£2,688GBP
- Report
- December 2022
- 117 Pages
From €3189EUR$3,450USD£2,688GBP
- Report
- December 2022
- 126 Pages
North America
From €3189EUR$3,450USD£2,688GBP
- Report
- December 2022
- 123 Pages
Africa, Middle East
From €3189EUR$3,450USD£2,688GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more